Opioidergic activation of the descending pain inhibitory system underlies placebo analgesia

Authors: Hiroyuki Neyama, Yuping Wu, Yuka Nakaya, Shigeki Kato, Tomoko Shimizu, Tsuyoshi Tahara, Mika Shigeta, Michiko Inoue, Kazunari Miyamichi, Natsuki Matsushita, Tomoji Mashimo, Yoshiki Miyasaka, Yi Dai, Koichi Noguchi, Yasuyoshi Watanabe, Masayuki Kobayashi, Kazuto Kobayashi, Yilong Cui

Published: 2025-01-15

DOI: 10.1126/sciadv.adp8494

Source: Full article


Abstract

Placebo analgesia is caused by inactive treatment, implicating endogenous brain function involvement. However, the neurobiological basis remains unclear. In this study, we found that μ-opioid signals in the medial prefrontal cortex (mPFC) activate the descending pain inhibitory system to initiate placebo analgesia in neuropathic pain rats. Chemogenetic manipulation demonstrated that specific activation of μ-opioid receptor–positive (MOR